SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters

Introduction and Objective: A new, first-in-class oral testosterone (T) replacement therapy product [T-undecanoate (TU) capsules] was recently approved by FDA to treat hypogonadal men. Clinical trials were conducted to evaluate, in part, the impact of oral TU therapy on important secondary efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Swerdloff, Ronald S, Amory, John K, Dobs, Adrian S, Wang, Christina, Danoff, Theodore M, Dudley, Robert E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368366/
http://dx.doi.org/10.1210/jendso/bvaa046.1297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368366/
http://dx.doi.org/10.1210/jendso/bvaa046.1297

Ejemplares similares